As this blog post relates to biomimetics and posts in the past have focused on social media you might expect to read about the exchange of media and the structure of popularity within online social networks but rather this blog post will refer to biomimetics as it relates to the potential for tooth tissue engineering and regeneration.
After the International Dental-Show in Cologne, The worlds largest dental trade fair that occurs every two years, there were a number of market implications that were identified that will affect the global market. In order to be an effective competitor in full dental restoration, organizations will need to offer a full line of products and services.
By 2012 worldwide, the dental implant and bone graft market is expected to top US$4.5 billion as developments in dental science and technology bring more advanced dental procedures into the general practice.
In implant dentistry, one of the most important aspects of the surgery is the aesthetic result. The factors determining a positive aesthetic treatment include bone, soft tissue, implant and abutment, as such, implant design and careful abutment selection are key factors in the process of obtaining a high aesthetics result.
Earlier this year Keystone Dental released The GENESIS implant system. The company redeveloped the thread design of implants and coated the implant with calcium and phosphorous to mimic the typography of human bone. The new thread design provides immediate function capability through its dual thread design for primary stability, while the patented BioSpark surface enhances secondary stability. The hydrophilic surface attracts blood to site stimulating angiogenesis, charged calcium and phosphorous ions fuel osteoblast activity while nanosurface topography supports adhesion and proliferation of osteoblasts.
While there are many components to dental implant treatment, besides the implant fixture, abutment and crown the bone and surrounding soft tissue play a crucial role in the achievement of an aesthetically pleasing dental implant treatment. Expanders made from Bio compatible hydrogel that use osmosis to increase in volume have been commonly used in plastic surgery, ophthalmology and dental procedures. In dental applications hydrogel expanders are commonly used for soft tissue expansion prior to augmentation of resorbed edentulous ridges.
"at least one in four implant procedures requires bone augmentation either prior to, or concurrent with, implant placement." -iData. US market for dental bone graft substitutes and other biomaterials.
At the 19th annual meeting of the European Association for Osseointegration in Glasgow October 2010, Straumann announced the market introduction of Straumann MembraGel, its new generation membrane for use in guided oral bone regeneration (GBR) procedures.
The increasing number of competitors within the dental implant market will threaten the ability of larger international dental implant manufacturers to sustain their global market share resulting in the growth of the dental profession and the dentistry market and an increase in value added services and innovative products offered by manufacturers while transforming the dental experience for patients.
Keystone Dental is an oral healthcare company dedicated to enhancing every patient smile by creating innovative solutions that restore the natural aesthetics of tissue, bone, and teeth. Keystone Dental's product portfolio includes: Genesis, The Biomimetic Implant System, the Prima Implant System, DynaMatrix Extracellular Membrane, DynaBlast bone graft substitute, and Accell Connexus, a next-generation BMP enhanced bone grafting product. Founded in 2006, Keystone Dental is committed to revolutionizing dental care by bringing joy to every patient experience.
The Straumann Group, with headquarters in Waldenburg, Switzerland and production plant in Villeret/Switzerland, is a leader in the field of implant dentistry. Straumann develops, produces and markets products worldwide for oral implantology in cooperation with the International Team for Oral Implantology, leading hospitals, research institutes and universities. Through the acquisition of Kuros Therapeutics, Straumann gained the necessary competency to develop tissue regeneration products for the dental market. Straumann products are all manufactured in Switzerland. The company is represented by subsidiaries in 14 countries worldwide, and in 35 countries by distributors.
|
